Braidwell »

Establishment Labs Holdings Ord shares owned by Braidwell

Quarter-by-quarter ownership of Establishment Labs Holdings Ord (ESTA) shares owned by Braidwell from 13F filings

Historical chart of Braidwell investment in Establishment Labs Holdings Ord

Tip: Access up to 7 years of quarterly data

All positions including Establishment Labs Holdings Ord held by Braidwell consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Establishment Labs Holdings Ord by Braidwell

Quarter filed Position value Share count Share price at filing
2026-03-31 $26M 464k 56.78

More positions owned by Braidwell

Caris Life Sciences (CAI)
Guardant Health Debt 1.250% 2/1 (Principal)
Repligen Corp Note 1.000%12/1 (Principal)
Neogenomics Note 0.250% 1/1 (Principal)
Neurocrine Biosciences (NBIX)
Glaukos (GKOS)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Xenon Pharmaceuticals (XENE)
Dianthus Therapeutics (DNTH)
Edgewise Therapeutics (EWTX)
Irhythm Technologies (IRTC)
Nuvalent Inc-a (NUVL)
Kodiak Sciences (KOD)
Cg Oncology (CGON)
Alphatec Hldgs Note 0.750% 3/1 (Principal)

View all positions for Braidwell

Top funds holding Establishment Labs Holdings Ord

JW Asset Management
Rtw Investments
Tyro Capital Management
Brown Advisory Holdings Incorporated
Susquehanna International
Findell Capital Management
Bamco
Nantahala Capital Management
Jane Street
Citadel Advisors
Mudita Advisors
William Blair Investment Management
Goldman Sachs Group
Caption Management
Rice Hall James & Associates

View all funds holding Establishment Labs Holdings Ord